Product List
![4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid](https://www.pudeepharm.com/wp-content/uploads/2021/03/641569-94-0.gif)
4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]ben…… | 641569-94-0
Nilotinib is for treating of leukemia resistant to imatinib. 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid is a key intermediate of ……
Nilotinib Intermediate | 641571-11-1
Nilotinib is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. it was develo……
(1s,2s,3R,5S) – (+) pinanediol | 18680-27-8
Bortezomib is for treating relapsed multiple myeloma and mantle cell lymphoma.
(1s,2s,3R,5S) – (+) pinanediol is a key intermediate of Bortezomibe.……
Bortezomib Intermediate | 179324-87-9
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma a……
(R)-Boroleu-(+)-pinanediol hydrochloride | 779357-85-6
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma a……
1-N-Boc-pyrrolidin-2-ylboronic acid | 149682-75-7
It is the intermediate of Bortezomib CAS: 179324-69-7. white crystalline powder. Purity 99% +, The minimum order quantity is 50 g. Packing size : 1……
(R)-BoroPro-(+)-Pinanediol-HCl | 147208-69-3
It is mainly used to synthesize Bortezomib CAS: 179324-69-7. white crystalline powder. Purity 98% +, The minimum order quantity is 10 g. Packing si……
Bortezomib | 179324-69-7
Bortezomib is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma a……
Nilotinib | 641571-10-0
Nilotinib is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia. it was develo……